JP2006521110A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521110A5
JP2006521110A5 JP2006507083A JP2006507083A JP2006521110A5 JP 2006521110 A5 JP2006521110 A5 JP 2006521110A5 JP 2006507083 A JP2006507083 A JP 2006507083A JP 2006507083 A JP2006507083 A JP 2006507083A JP 2006521110 A5 JP2006521110 A5 JP 2006521110A5
Authority
JP
Japan
Prior art keywords
acid sequence
nucleic acid
seq
sequence shown
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507083A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006521110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/007451 external-priority patent/WO2004084804A2/en
Publication of JP2006521110A publication Critical patent/JP2006521110A/ja
Publication of JP2006521110A5 publication Critical patent/JP2006521110A5/ja
Pending legal-status Critical Current

Links

JP2006507083A 2003-03-24 2004-03-10 肺癌の検出およびモニタリング Pending JP2006521110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45726103P 2003-03-24 2003-03-24
US50299503P 2003-09-15 2003-09-15
PCT/US2004/007451 WO2004084804A2 (en) 2003-03-24 2004-03-10 Detection and monitoring of lung cancer

Publications (2)

Publication Number Publication Date
JP2006521110A JP2006521110A (ja) 2006-09-21
JP2006521110A5 true JP2006521110A5 (enExample) 2007-04-19

Family

ID=33101281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507083A Pending JP2006521110A (ja) 2003-03-24 2004-03-10 肺癌の検出およびモニタリング

Country Status (6)

Country Link
US (1) US20070042368A1 (enExample)
EP (1) EP1606303A4 (enExample)
JP (1) JP2006521110A (enExample)
AU (1) AU2004224448A1 (enExample)
CA (1) CA2520512A1 (enExample)
WO (1) WO2004084804A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004077021A2 (en) * 2003-02-27 2004-09-10 Lesko Stephen A Standardized evaluation of therapeutic efficacy based on cellular biomarkers
US8921102B2 (en) * 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
HUE031848T2 (en) 2008-09-20 2017-08-28 Univ Leland Stanford Junior Non-invasive diagnosis of fetal aneuploidy by sequencing
WO2024026284A2 (en) * 2022-07-25 2024-02-01 Interius Biotherapeutics, Inc. Mutated polypeptides, compositions comprising the same, and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US660833A (en) * 1900-05-22 1900-10-30 Harry W Bell Partition.
US5795723A (en) * 1994-05-06 1998-08-18 Fred Hutchinson Cancer Research Center Expression of neurogenic bHLH genes in primitive neuroectodermal tumors
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6518256B1 (en) * 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) * 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) * 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) * 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6210883B1 (en) * 1998-03-18 2001-04-03 Corixa Corporation Compounds and methods for diagnosis of lung cancer
US6821518B1 (en) * 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
US20030125245A1 (en) * 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6686447B1 (en) * 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) * 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1366157A2 (en) * 2000-06-29 2003-12-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1343886A2 (en) * 2000-07-11 2003-09-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2002309583A1 (en) * 2001-04-18 2002-11-05 Protein Desing Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US20030103994A1 (en) * 2001-06-28 2003-06-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Similar Documents

Publication Publication Date Title
US8772464B2 (en) Aptamer regulated nucleic acids and uses thereof
JP2024123233A5 (enExample)
JP2004159661A5 (enExample)
JP2020028293A5 (enExample)
Jeong et al. BRAF V600E mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR
WO2001075171B1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
JP2009523005A5 (enExample)
CA2513780A1 (en) Method to detect prostate cancer from a urine sample
JP2009533066A5 (enExample)
JP2021529540A (ja) 酵素利用ナノテクノロジーを用いた、モジュール方式の視覚的な核酸検出
JPWO2020112869A5 (enExample)
JP2006521110A5 (enExample)
CN118139991A (zh) 诊断炎症性肠道疾病
US20230167490A1 (en) Pseudo-complementary bases in genotyping and nucleic acid sequencing
CN106676191A (zh) 一种用于结肠腺癌的分子标志物
EP3255155A1 (en) Compositions and methods for detecting bv-associated bacterial nucleic acid
ES2712941T3 (es) Método para la detección de mutaciones en BRAF y PI3K
CN111690772A (zh) 一种新冠病毒核酸检测试剂盒、制备方法及应用
JPWO2021046278A5 (enExample)
WO2024077162A2 (en) Probes for improving coronavirus sample surveillance
CN101210269A (zh) 用于检测戊型肝炎病毒的lamp扩增用核酸引物组
AU2022375767A1 (en) Off-target blocking sequences to improve target discrimination by polymerase chain reaction
KR20100012319A (ko) 패혈증­유발 미생물의 분류 및 동정 방법
Schopf et al. Mycobacterium tuberculosis detection via rolling circle amplification
US11225684B2 (en) Method and device for SNP genotyping